Jonathan Kimmelman: “Clinical Trials of New Drugs: Do Patients Benefit from Participating in Clinical Trials?”

In his presentation, the James McGill Professor of Biomedical Ethics will parse various benefits trial participation might offer patients and present evidence his team has gathered. Kimmelman will identify key unresolved questions, and describe some of the moral and policy implications of his analysis of trial benefit. Find out more!